Senores Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 11, 2025, titled "Senores Pharmaceuticals, Inc. announces the approval and launch of Deferiprone Tablets USP, 500 mg & 1000 mg which will be marketed by Dr. Reddy s Laboratories Inc. in the US market".